TeleClinic GmbH, headquartered in Germany, is a pioneering force in the telemedicine industry, specialising in digital healthcare solutions. Founded in 2015, the company has rapidly established itself as a leader in providing accessible medical consultations and prescriptions through its innovative online platform. With a focus on enhancing patient experience, TeleClinic offers a range of services, including virtual doctor consultations and prescription management, making healthcare more convenient and efficient. Its unique approach combines advanced technology with a user-friendly interface, ensuring that patients receive timely medical advice from qualified professionals. Recognised for its commitment to quality and accessibility, TeleClinic has achieved significant milestones, positioning itself as a trusted partner in the evolving landscape of digital health. The company continues to expand its operational reach across Germany, contributing to the transformation of healthcare delivery in the region.
How does TeleClinic GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
TeleClinic GmbH's score of 60 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TeleClinic GmbH, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of DocMorris AG, which may influence its climate-related initiatives and reporting practices. As of now, TeleClinic GmbH has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi). The lack of specific emissions data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. Given its affiliation with DocMorris AG, any potential climate commitments or performance metrics may be derived from the parent company's initiatives. However, no specific details regarding emissions or reduction targets from DocMorris AG have been provided in this context. In summary, TeleClinic GmbH is currently without reported emissions data or defined climate commitments, reflecting a need for further development in its sustainability practices.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 81,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 3,031,000 | 0,000,000 | 0,000,000 | 000,000 |
| Scope 3 | 4,971,000 | 0,000,000 | 0,000,000 | 0,000,000 |
TeleClinic GmbH's Scope 3 emissions, which increased by 2% last year and increased by approximately 80% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 59% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
TeleClinic GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.